Dhiman R K, Seth A K, Jain S, Chawla Y K, Dilawari J B
Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Dig Dis Sci. 1998 Jun;43(6):1311-6. doi: 10.1023/a:1018876328561.
Viral hepatitis is the commonest cause of fulminant hepatic failure (FHF) in developing countries. We evaluated the early indicators of prognosis in these patients by multivariate analysis. The records of 204 consecutive patients with acute liver failure admitted with hepatic encephalopathy over five years were studied. The etiology of these patients included virus related in 186 (91.1%), drug induced in 15 (7.4%), Wilson's disease in one (0.5%), acute Budd-Chiari syndrome in one (0.5%), and malignant infiltration in one (0.5%). Patients with FHF complicating viral hepatitis were analyzed by univariate and multivariate analysis. These patients were further subclassified depending upon the interval between the onset of jaundice and the onset of encephalopathy into hyperacute (HALF; interval 0-7 days), acute (ALF; interval 8-28 days) and subacute liver failure (SALF; interval 4-12 weeks). Sixty (32.3%) patients with viral hepatitis survived. Univariate analysis showed that the interval between onset of encephalopathy and onset of jaundice, grade of encephalopathy, raised intracranial pressure, prothrombin time, and serum bilirubin levels on admission were related to outcome in these patients. Multivariate logistic regression analysis showed that the presence of raised intracranial pressure at the time of admission, prothrombin time >100 sec on admission, age (>50 yr), and onset of encephalopathy seven days after onset of jaundice were associated with poor prognosis. Forty seven (37.0%) of 129 patients with HALF survived compared with 9 (22.5%) of 40 with ALF and 4 (21.1%) of 19 with SALF (P = NS). Raised intracranial pressure was more frequent in patients with HALF (48.8%) than in patients with ALF (32.5%) and SALF (15.8%; P = 0.01), while clinically detectable ascites was more frequent in patients with SALF (78.9%) compared with HALF (19.7%) and ALF (37.5%; P < 0.0001). The factors adversely affecting the outcome in our patients with FHF complicating viral hepatitis include presence of overt clinical features of raised ICP at the time of hospitalization, prothrombin time (>100 sec) on admission, age (>50 yr), and onset of encephalopathy seven days after onset of jaundice.
在发展中国家,病毒性肝炎是暴发性肝衰竭(FHF)最常见的病因。我们通过多因素分析评估了这些患者预后的早期指标。对连续五年收治的204例伴有肝性脑病的急性肝衰竭患者的记录进行了研究。这些患者的病因包括病毒相关性186例(91.1%)、药物性15例(7.4%)、威尔逊病1例(0.5%)、急性布加综合征1例(0.5%)、恶性浸润1例(0.5%)。对并发病毒性肝炎的FHF患者进行了单因素和多因素分析。这些患者根据黄疸出现至脑病出现的间隔时间进一步分为超急性(HALF;间隔0 - 7天)、急性(ALF;间隔8 - 28天)和亚急性肝衰竭(SALF;间隔4 - 12周)。60例(32.3%)病毒性肝炎患者存活。单因素分析显示,脑病出现至黄疸出现的间隔时间、脑病分级、颅内压升高、凝血酶原时间以及入院时血清胆红素水平与这些患者的预后相关。多因素逻辑回归分析显示,入院时颅内压升高、入院时凝血酶原时间>100秒、年龄(>50岁)以及黄疸出现后7天出现脑病与预后不良相关。129例HALF患者中有47例(37.0%)存活,而40例ALF患者中有9例(22.5%)存活,19例SALF患者中有4例(21.1%)存活(P = 无显著性差异)。HALF患者颅内压升高比ALF患者(32.5%)和SALF患者(15.8%)更常见(P = 0.01),而临床上可检测到的腹水在SALF患者中(78.9%)比HALF患者(19.7%)和ALF患者(37.5%)更常见(P < 0.0001)。影响我们并发病毒性肝炎的FHF患者预后的不利因素包括住院时存在明显的颅内压升高临床特征、入院时凝血酶原时间(>100秒)、年龄(>50岁)以及黄疸出现后7天出现脑病。